» Authors » Mohammad Reza Beyranvand

Mohammad Reza Beyranvand

Explore the profile of Mohammad Reza Beyranvand including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 41
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Beyranvand M, Asadpour Piranfar M, Solaymani-Dodaran M, Mohebbi N, Taati R, Sheibani M, et al.
Clin Drug Investig . 2025 Jan; 45(2):101-110. PMID: 39873854
Background: Primary percutaneous coronary intervention (PPCI) and fibrinolytic or thrombolytic therapy are common treatments for ST-elevation myocardial infarction (STEMI). Primary percutaneous coronary intervention is more effective than thrombolytic therapy, but...
2.
Gorgani F, Naderian M, Khatibzadeh S, Amin A, Farzi Y, Beyranvand M, et al.
BMC Health Serv Res . 2024 Oct; 24(1):1317. PMID: 39478583
Background: Chronic diseases, such as heart failure with reduced ejection fraction (HFrEF), remain significant factors in the healthcare burden in Iran. Healthcare systems must have comprehensive data on the current...
3.
Safiri S, Mousavi S, Motlagh Asghari K, Nejadghaderi S, Aletaha R, Sullman M, et al.
Sci Rep . 2024 Jun; 14(1):13617. PMID: 38871791
High systolic blood pressure (HSBP) is associated with several metabolic and non-metabolic disorders. This research aimed to document the deaths and disability-adjusted life-years (DALYs) attributable to HSBP in the Middle...
4.
Beyranvand M, Manhoobi H, Shahraz S, Kolahi A
J Tehran Heart Cent . 2023 Aug; 18(2):82-86. PMID: 37637282
Background: Cardiovascular diseases, specifically acute myocardial infarction (AMI), are the leading cause of death worldwide. In this review, we explain the characteristics of AMI in Iran. Methods: We searched PubMed,...
5.
Shahraz S, Shahin S, Farzi Y, Modirian M, Shahbal N, Azmin M, et al.
Arch Iran Med . 2023 Aug; 26(3):126-137. PMID: 37543935
Background: Assessment of quality and cost of medical care has become a core health policy concern. We conducted a nationwide survey to assess these measures in Iran as a developing...
6.
Tabaghi S, Sheibani M, Khaheshi I, Miri R, Haji Aghajani M, Safi M, et al.
Clin Cardiol . 2023 Jul; 46(11):1319-1325. PMID: 37501642
Background: Previous studies evaluated the impact of particle matters (PM) on the risk of acute myocardial infarction (AMI) based on local registries. Hypothesis: This study aimed to evaluate possible short...
7.
Safiri S, Nejadghaderi S, Karamzad N, Kaufman J, Carson-Chahhoud K, Bragazzi N, et al.
Front Endocrinol (Lausanne) . 2022 Aug; 13:879890. PMID: 35966097
Background: To report the burden of cancers attributable to high fasting plasma glucose (HFPG) by sex, age, location, cancer type and Socio-demographic Index (SDI) over the period 1990 to 2019...
8.
Fouladseresht H, Talepoor A, Eskandari N, Norouzian M, Ghezelbash B, Beyranvand M, et al.
Front Immunol . 2022 Feb; 12:785946. PMID: 35126355
Although cellular and molecular mediators of the immune system have the potential to be prognostic indicators of disease outcomes, temporal interference between diseases might affect the immune mediators, and make...
9.
Vasheghani M, Sarvghadi F, Beyranvand M, Emami H
Diabetol Metab Syndr . 2020 Dec; 12(1):102. PMID: 33292470
Background: Long QT interval (QT) and abnormal QT dispersion (QTd) are associated with sudden death. The relationship between cardiac autonomic neuropathy (CAN) and QT indices in type 2 diabetic patients...
10.
Vasheghani M, Sarvghadi F, Beyranvand M
Diabetes Metab Syndr Obes . 2019 May; 12:581-587. PMID: 31118721
Cardiac autonomic neuropathy (CAN) is one of major complications of diabetes mellitus (DM) that increases the risk of cardiovascular disorders, abnormal ventricular depolarization with poor prognosis as well as increased...